Ironwood Pharmaceuticals | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Acadia Pharmaceuticals USD 681.58M 74.42M 2025-03
Agios Pharmaceuticals USD 78.96M 2.72M 2025-03
Almirall EUR 377.1M 47.69M 2024-12
Alnylam Pharmaceuticals USD 1.02B 53.23M 2025-03
Amarin USD 156.94M 58.98M 2024-09
Ardelyx USD 48.65M 8.78M 2024-12
Astellas Pharma JPY 188.37B 8.51B 2025-03
AstraZeneca USD 5.23B 258M 2025-03
Charles River Laboratories USD 229.36M 34.75M 2025-03
Exact Sciences USD 6.11M 773K 2025-03
Halozyme Therapeutics USD 176.33M 60.48M 2025-03
Incyte USD 2.41B 720.83M 2025-03
Ironwood Pharmaceuticals USD 88.56M 348K 2024-12
MacroGenics USD 182.84M 3.22M 2024-12
Moderna USD 1.62B 304M 2025-03
Myriad Genetics USD 91.8M 10.6M 2025-03
Pacira USD 283.61M 6.84M 2025-03
PTC Therapeutics USD 2.03B 1.25B 2025-03
Sarepta Therapeutics USD 240.87M 862.14M 2025-03
Takeda JPY 385.11B 109.01B 2025-03
Ultragenyx Pharmaceutical USD 563M 389.27M 2025-03



Ironwood Pharmaceuticals Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.